Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Björklund, Peyman ^a   Lindberg, Daniel ^a   Åkerström, Göran ^a   Westin, Gunnar ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYTOSINE; DNA FRAGMENT; GUANINE; ONCOPROTEIN; PROTEIN CTNNB1; THYMINE; CTNNB1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; EXON; GENE DUPLICATION; GENE MUTATION; GENE NUMBER; GENETIC REGULATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PARATHYROID ADENOMA; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; RESTRICTION MAPPING; SWEDEN; WESTERN BLOTTING; ADENOMA; CHEMISTRY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETICS; HOMOZYGOTE; MUTATION; NUCLEOTIDE SEQUENCE; PARATHYROID TUMOR; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ADENOMA; BETA CATENIN; BLOTTING, WESTERN; DNA MUTATIONAL ANALYSIS; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARATHYROID NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; UP-REGULATION;

EID: 46349098659     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-53     Document Type: Article

References (30)

1. Marx S Hyperparathyroid and hypoparathyroid disorders N Engl J Med 2000, 343:1863-1875 10.1056/NEJM200012213432508 11117980
2. Arnold A Shattuck TM Mallya SM Krebs LJ Costa J Gallagher J Wild Y Saucier K Molecular pathogenesis of primary hyperparathyroidism J Bone Miner Res 2002, 17(Suppl 2):N30-36 12412775
3. Åkerström G Hellman P Primary hyperparathyroidism Curr Opin Oncol 2004, 16:1-7 10.1097/00001622-200401000-00002 14685084
4. Åkerström G Hellman P Hessman O Segersten U Westin G Parathyroid glands in calcium regulation and human disease Ann N Y Acad Sci 2005, 1040:53-58 10.1196/annals.1327.005 15891005
5. Polakis P The oncogenic activation of β-catenin Curr Opin Genet Dev 1999, 9:15-21 10.1016/S0959-437X(99)80003-3 10072352
6. Lustig B Behrens J The Wnt signaling pathway and its role in tumor development J Cancer Res Clin Oncol 2003, 129:199-221 12707770
7. Giles RH van Es JH Clevers H Caught up in a Wnt storm: Wnt signaling in cancer Biochim Biophys Acta 2003, 1653:1-24 12781368
8. Polakis P The many ways of Wnt in cancer Curr Opin Genet Dev 2007, 17:45-51 10.1016/j.gde.2006.12.007 17208432
9. Major MB Camp ND Berndt JD Yi X Goldenberg SJ Hubbert C Biechele TL Gingras AC Zheng N Maccoss MJ Angers S Moon RT Wilms tumor suppressor WTX negatively regulates WNT/β-catenin signaling Science 2007, 316:1043-1046 10.1126/science/1141515 17510365
10. Björklund P Åkerström G Westin G Accumulation of nonphosphorylated β-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors J Clin Endocrinol Metab 2007, 92:338-344 10.1210/jc.2006-1197 17047023
11. Björklund P Åkerström G Westin G An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/β-catenin signaling PLoS Med 2007, 4(11):e328 2082644 18044981 10.1371/journal.pmed.0040328
12. Ikeda S Ishizaki Y Shimizu Y Fujimori M Ojima Y Okajima M Sugino K Asahara T Immunohistochemistry of cyclin D1 and β-catenin, and mutational analysis of exon 3 of β-catenin gene in parathyroid tumors Int J Oncol 2002, 20:463-466 11836555
13. Costa-Guda J Arnold A Absence of stabilizing mutations of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas J Clin Endocrinol Metab 2007, 92:1564-1566 10.1210/jc.2006-2554 17284619
14. van Noort M Meeldijk J Zee van der R Destree O Clevers H Wnt signaling controls the phosphorylation status of beta-catenin J Biol Chem 2002, 277:17901-17905 10.1074/jbc.M111635200 11834740
15. Fujimori M Ikeda S Shimizu Y Okajima M Asahara T Accumulation of β-catenin protein and mutations in exon 3 of β-catenin gene in gastrointestinal carcinoid tumor Cancer Res 2001, 61:6656-6659 11559529
16. Orford K Crockett C Jensen JP Weissman AM Byers SW Serine phosphorylation-regulated ubiquitination and degradation of β-catenin J Biol Chem 1997, 272:24735-24738 10.1074/ jbc.272.40.24735 9312064
17. Rubinfeld B Robbins P El-Gamil M Albert I Porfiri E Polakis P Stabilization of β-catenin by genetic defects in melanoma cell lines Science 1997, 275:1790-1792 10.1126/science.275.5307.1790 9065403
18. Williams BO Barish GD Klymkowsky MW Varmus HE A comparative evaluation of β-catenin and plakoglobin signaling activity Oncogene 2000, 19:5720-5728 10.1038/sj.onc.1203921 11126358
19. Ilyas M Tomlinson IPM Rowan A Pignatelli M Bodmer WF β-Catenin mutations in cell lines established from human colorectal cancers Proc Natl Acad Sci USA 1997, 94:10330-10334 23362 9294210 10.1073/ pnas.94.19.10330
20. Suzuki H Watkins DN Jair KW Schuebel KE Markowitz SD Chen WD Pretlow TP Yang B Akiyama Y Van Engeland M Toyota M Tokino T Hinoda Y Imai K Herman JG Baylin SB Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat Genet 2004, 36:417-422 10.1038/ ng1330 15034581
21. Semba S Kusumi R Moriya T Sasano H Nuclear accumulation of β-catenin in human endocrine tumors: Association with Ki-67 (MIB-1) proliferative activity Endocr Pathol 2000, 11:243-250 10.1385/ EP:11:3:243 12114696
22. Morin PJ Sparks AB Korinek V Barker N Clevers H Vogelstein B Kinzler KW Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 1997, 275:1787-1790 10.1126/ science.275.5307.1787 9065402
23. Sparks AB Morin PJ Vogelstein B Kinzler KW Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer Cancer Res 1998, 58:1130-1134 9515795
24. Omholt K Platz A Ringborg U Hansson J Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma Int J Cancer 2001, 92:839-842 10.1002/ ijc.1270 11351304
25. Reifenberger J Knobbe CB Wolter M Blaschke B Schulte KW Pietsch T Ruzicka T Reifenberger G Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC Int J Cancer 2002, 100:549-556 10.1002/ijc.10512 12124804
26. Pollock PM Hayward N Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines Melanoma Res 2002, 12:183-186 10.1097/ 00008390-200204000-00013 11930117
27. Demunter A Libbrecht L Degreef H De Wolf-Peeters C Oord van den JJ Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations Mod Pathol 2002, 15:454-461 10.1038/modpathol.3880546 11950921
28. Johnson V Volikos E Halford SE Eftekhar Sadat ET Popat S Talbot I Truninger K Martin J Jass J Houlston R Atkin W Tomlinson IPM Silver ARJ Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome Gut 2005, 54:264-267 1774848 15647192 10.1136/gut.2004.048132
29. Luchtenborg M Weijenberg MP Wark PA Saritas AM Roemen GM van Muijen GN de Bruine AP Brandt van den PA de Goeij AF Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study BMC Cancer 2005, 5:160 1334229 16356174 10.1186/1471-2407-5-160
30. Thorstensen L Lind GE Lovig T Diep CB Meling GI Rognum TO Lothe RA Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability Neoplasia 2005, 7:99-108 1501125 15802015 10.1593/neo.04448